SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
245.0 |
um |
6.1 |
14.94 |
ex vivo videomicroscopy |
0.0 |
0 |
69562 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
246.0 |
um |
10.5 |
25.72 |
ex vivo videomicroscopy |
0.0 |
0 |
69580 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
245.0 |
um |
8.2 |
20.09 |
ex vivo videomicroscopy |
0.0 |
0 |
69559 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
0.9% sodium chloride solution (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(max dia - baseline dia) /max dia] x 100 |
38.0 |
% |
2.1 |
5.14 |
ex vivo videomicroscopy |
0.0 |
0 |
69572 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
248.0 |
um |
7.1 |
18.78 |
ex vivo videomicroscopy |
0.0 |
0 |
69565 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(max dia - baseline dia) /max dia] x 100 |
40.0 |
% |
2.1 |
5.56 |
ex vivo videomicroscopy |
0.0 |
0 |
69566 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
237.0 |
um |
6.6 |
17.46 |
ex vivo videomicroscopy |
0.0 |
0 |
69568 |
732 |
SS.BN-(D13Rat77-D13Rat105)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(max dia - baseline dia) /max dia] x 100 |
42.0 |
% |
1.9 |
4.65 |
ex vivo videomicroscopy |
0.0 |
0 |
68116 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(max dia - baseline dia) /max dia] x 100 |
38.0 |
% |
2.1 |
5.56 |
ex vivo videomicroscopy |
0.0 |
0 |
69569 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
39.0 |
% |
1.7 |
4.16 |
ex vivo videomicroscopy |
0.0 |
0 |
69581 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
246.0 |
um |
8.9 |
21.8 |
ex vivo videomicroscopy |
0.0 |
0 |
69586 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
0.9% sodium chloride solution (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
249.0 |
um |
8.5 |
20.82 |
ex vivo videomicroscopy |
0.0 |
0 |
69571 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
246.0 |
um |
3.7 |
8.27 |
ex vivo videomicroscopy |
0.0 |
0 |
69577 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
255.0 |
um |
2.9 |
6.48 |
ex vivo videomicroscopy |
0.0 |
0 |
69583 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
|
248.0 |
um |
6.4 |
20.24 |
ex vivo videomicroscopy |
0.0 |
0 |
68112 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
54.0 |
% |
2.2 |
4.92 |
ex vivo videomicroscopy |
0.0 |
0 |
69578 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
48.0 |
% |
1.9 |
4.25 |
ex vivo videomicroscopy |
0.0 |
0 |
69584 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
|
252.0 |
um |
3.4 |
10.2 |
ex vivo videomicroscopy |
0.0 |
0 |
67245 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(max dia - baseline dia) /max dia] x 100 |
37.0 |
% |
2.7 |
6.61 |
ex vivo videomicroscopy |
0.0 |
0 |
69560 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(max dia - baseline dia) /max dia] x 100 |
41.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
0.0 |
0 |
69563 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
247.0 |
um |
7.8 |
17.44 |
ex vivo videomicroscopy |
0.0 |
0 |
69574 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(max dia - baseline dia) /max dia] x 100 |
37.0 |
% |
1.5 |
3.35 |
ex vivo videomicroscopy |
0.0 |
0 |
69575 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
44.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
0.0 |
0 |
69587 |
732 |
SS.BN-(D13Rat77-D13Rat105)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
260.0 |
um |
2.6 |
6.37 |
ex vivo videomicroscopy |
0.0 |
0 |
68115 |
732 |
SS.BN-(D13Rat124-D13Rat101)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
260.0 |
um |
5.8 |
12.97 |
ex vivo videomicroscopy |
0.0 |
0 |
68118 |
732 |
SS/JrHsdMcwi |
percent change in middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
[(max dia - baseline dia) /max dia] x 100 |
42.0 |
% |
3.3 |
9.9 |
ex vivo videomicroscopy |
0.0 |
0 |
67246 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(max dia - baseline dia) /max dia] x 100 |
49.0 |
% |
2.4 |
6.35 |
ex vivo videomicroscopy |
0.0 |
0 |
69557 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
[(max dia - baseline dia) /max dia] x 100 |
41.0 |
% |
3.2 |
10.12 |
ex vivo videomicroscopy |
0.0 |
0 |
68113 |
732 |
SS.BN-(D13Rat124-D13Rat101)/Mcwi |
percent change in middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(max dia - baseline dia) /max dia] x 100 |
41.0 |
% |
1.8 |
4.02 |
ex vivo videomicroscopy |
0.0 |
0 |
68119 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
255.0 |
um |
5.2 |
13.76 |
ex vivo videomicroscopy |
0.0 |
0 |
69556 |
732 |